Compare Illumina, Inc. (ILMN) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs United States Oil ETF — how do they compare? Illumina, Inc. trades at $189.76 (market cap $27.94B), while United States Oil ETF trades at $128.62. The key difference: Illumina, Inc. is trading nearer its 52-week high, United States Oil ETF nearer its low. Which is the better fit depends on your goals.
| ILMN | USO | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | — |
52-Week High | $194.33 | $152.96 |
52-Week Low | $91.00 | $66.17 |
Enterprise Value | $29.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
USO is trading at $125.51, up 1.25% with strong bullish momentum driven by Middle East supply disruptions. Technical indicators show overall bullish sentiment with moving averages supporting the uptrend, though RSI levels suggest potential overbought conditions. Recent news highlights escalating geopolitical tensions in the Strait of Hormuz, pushing oil prices higher and benefiting the fund's performance.
The outlook remains positive as supply constraints and geopolitical risks continue to support oil prices, though overbought technical conditions warrant caution. Key risks include potential conflict de-escalation and OPEC demand adjustments. Current momentum favors continued strength, but volatility remains elevated due to geopolitical developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
